chirality in drugs
Your body is built almost entirely from single-handed molecules — proteins folded from left-handed amino acids, DNA wound from right-handed sugars. So when a drug molecule arrives, the proteins it must dock into are themselves chiral, and they can tell a drug's left hand from its right. This is why the handedness of a medicine is not a chemical footnote but a matter of life and health.
Many drugs are chiral, meaning they exist as two enantiomers. Because a receptor or enzyme is a chiral pocket, the two enantiomers can fit utterly differently, like a right hand into a right glove versus a left hand jammed into it. Often one enantiomer (the 'eutomer') carries the desired therapeutic effect while the other (the 'distomer') is weaker, inactive, causes side effects, or in the worst case is toxic. The two enantiomers can also be metabolized at different rates and even interconvert in the body, which complicates the picture further.
The hardest lesson came from thalidomide in the late 1950s: marketed as a racemic mixture to treat morning sickness, one enantiomer was an effective sedative while the other was a powerful teratogen that caused severe birth defects. Tragically, even giving only the 'safe' enantiomer would not have helped, because the body racemizes thalidomide back into a mixture. The disaster transformed drug regulation: agencies now scrutinize each enantiomer separately, and developing single-enantiomer drugs (and the asymmetric chemistry to make them) became a central goal of the pharmaceutical industry.
Ibuprofen is sold as a racemate, but only the (S)-enantiomer relieves pain; the (R)-form is largely inactive, though the body slowly converts some of it to the active (S). Naproxen, by contrast, is sold as the single (S)-enantiomer because its (R)-form is liver-toxic — a deliberate design choice driven entirely by chirality.
One hand heals, the other may be useless or harmful — chirality decides.
A common oversimplification is that the 'wrong' enantiomer is always toxic. Usually it is simply less active or inert, and sometimes both enantiomers are useful. The thalidomide tragedy is genuinely severe but also genuinely exceptional — and a key part of its lesson is that separating the enantiomers would not have prevented it, because thalidomide racemizes in the body.